Jane E. Brock
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 36
- Cancer Genomics and Diagnostics 21
-
- Breast Lesions and Carcinomas 16
- Co-authors
- Deborah A. R. Dillon (7 shared papers)Eric P. Winer (9 shared papers)Susan C. Lester (10 shared papers)Mehra A. Golshan (11 shared papers)Andrea L. Richardson (4 shared papers)Sara Tolaney (8 shared papers)William Thomas Barry (6 shared papers)Lydia Eleanor Pace (2 shared papers)
- Journals
- Nature Communications (14 papers)Nature (7 papers)American Journal of Clinical Pathology (6 papers)Breast Cancer Research and Treatment (5 papers)The Oncologist (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jane E. Brock
90 papers receiving 17.5k citations
Jane E. Brock's Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 7.1k
- Oncology 4.5k
- Genetics 1.8k
- Molecular Biology 3.8k
- Pathology and Forensic Medicine 909
Countries citing papers authored by Jane E. Brock
This map shows the geographic impact of Jane E. Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Brock more than expected).
Fields of papers citing papers by Jane E. Brock
This network shows the impact of papers produced by Jane E. Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Brock. The network helps show where Jane E. Brock may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane E. Brock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Hit paper breakdown → | 2014 | 2494 |
| 2 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 3 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 4 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences Hit paper breakdown → | 2016 | 1681 |
| 5 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 730 |
| 6 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors Hit paper breakdown → | 2017 | 635 |
| 7 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 8 | Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research Hit paper breakdown → | 2017 | 560 |
| 9 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 489 |
| 10 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 428 |
| 11 | Comprehensive molecular characterization of mitochondrial genomes in human cancers Hit paper breakdown → | 2020 | 319 |
| 12 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 315 |
| 13 | Genomic basis for RNA alterations in cancer Hit paper breakdown → | 2020 | 310 |
| 14 | The landscape of viral associations in human cancers Hit paper breakdown → | 2020 | 293 |
| 15 | Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue Hit paper breakdown → | 2022 | 279 |
| 16 | 2016 | 242 | |
| 17 | 2015 | 221 | |
| 18 | 2021 | 200 | |
| 19 | 2020 | 198 | |
| 20 | 2020 | 190 |
About Jane E. Brock
Jane E. Brock is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 90 papers that have together received 17.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (36 papers), Cancer Genomics and Diagnostics (21 papers), Breast Lesions and Carcinomas (16 papers), Cancer Immunotherapy and Biomarkers (7 papers), Genomic variations and chromosomal abnormalities (6 papers), HER2/EGFR in Cancer Research (5 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Global Cancer Incidence and Screening (2 papers). The work is most often cited by research in Cancer Research (7.1k citations), Oncology (4.5k citations), Genetics (1.8k citations), Molecular Biology (3.8k citations) and Pathology and Forensic Medicine (909 citations). Jane E. Brock has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Deborah A. R. Dillon, Eric P. Winer, Susan C. Lester, Mehra A. Golshan, Andrea L. Richardson, Sara Tolaney, William Thomas Barry, Lydia Eleanor Pace, Lawrence N. Shulman and Yehoda M. Martei. Their work appears in journals such as Nature Communications, Nature, American Journal of Clinical Pathology, Breast Cancer Research and Treatment and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.